Teva Avoids Bankruptcy, Huge Upside

|
About: Teva Pharmaceutical Industries Limited (TEVA)
by: Michael Wiggins De Oliveira
This article is exclusive for subscribers.
Summary

Teva refinances all-important 2021 stack.

Teva's turnaround is picking up momentum.

Teva is simply too cheap now.

***This article was first released to readers in my Marketplace service***

Investment Thesis

Teva (NYSE:TEVA) is the biggest generics manufacturer in the world. It makes strong free cash flow and is very cheaply